Professional Society Guidelines

Use of CGM in Pediatrics – A Consensus Statement

You are here

Consensus Statement, Pediatric Diabetes (2012)

This consensus statement has been developed by a world-wide expert panel of pediatric endocrinologists and represents the clinical guidance of the use of continuous glucose monitoring (CGM) from the European Society for Pediatric Endocrinology, the Pediatric Endocrine Society and the International Society for Pediatric and Adolescent Diabetes. Use of real-time CGM provides the following benefits:

  • Improved overnight control with hypoglycemia alarms
  • Enhanced understanding of diabetes management teaching
  • Improved daytime bolus dosing with trend arrows and hyper- and hypoglycemia alarms for real-time adjustements
  • Improved management of acute illnesses

Source: Phillip M, Danne T, Shalitin S, Buckingham B, Laffel L, Tamboralne W, Battelino T and Consensus Forum Participants. Pediatric Diabetes, 2012.

View the article.

More Professional Society Guidelines

For the first time the American Diabetes Association (ADA) has added a dedicated section on diabetes technology to the Standards of Medical Care in Diabetes. In this year’s guidelines, CGM is further defined as either real-time (rt)CGM or...

The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes-2019” are the ADA’s clinical practice recommendations regarding the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality...

The Endocrine Society recently published new diabetes treatment guidelines,1,2 which may help providers to guide patients on adjusting pre-meal and ≥3 hour post-meal insulin doses using Dexcom G5 Mobile CGM trend arrows. Below, find...